UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer

Annals of oncology, 2012-12, Vol.23 (12), p.3104-3110

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen

Annals of oncology, 2012-03, Vol.23 (3), p.785-790

2012

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer

Annals of internal medicine, 2000-03, Vol.132 (5), p.364

2000

Link zum Volltext

Verfügbarkeit prüfen

Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470

The New England journal of medicine, 1998-04, Vol.338 (14), p.991-992

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix

Journal of clinical oncology, 1997-02, Vol.15 (2), p.625-631

1997

Link zum Volltext

Verfügbarkeit prüfen

Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2733-2739

2000

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

Clinical cancer research, 1997-09, Vol.3 (9), p.1501-1505

1997

Link zum Volltext

Verfügbarkeit prüfen

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines

Clinical cancer research, 1998-12, Vol.4 (12), p.3069-3076

1998

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

Clinical & experimental metastasis, 2000, Vol.18 (1), p.83-88

2000

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience

Oncology reports, 1998-07, Vol.5 (4), p.939

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles

Journal of cancer research and clinical oncology, 2003-10, Vol.129 (10), p.549-555

2003

Link zum Volltext

Verfügbarkeit prüfen

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

International journal of gynecological cancer, 2001-09, Vol.11 (5), p.359-364

2001

Link zum Volltext

Verfügbarkeit prüfen

Absence of epidermal growth factor receptor mutations in cervical cancer

International journal of gynecological cancer, 2008-07, Vol.18 (4), p.749-754

2008

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic syndromes of gynecologic neoplasms

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1272-1282

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum

Clinical cancer research, 1996-05, Vol.2 (5), p.837-842

1996

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour‐infiltrating lymphocyte (TIL)‐derived T cell lines and established tumour cell lines

Clinical and experimental immunology, 1998-05, Vol.112 (2), p.172-180

1998

Link zum Volltext

Verfügbarkeit prüfen

Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Malignancies in the Lungs

Annals of the New York Academy of Sciences, 2000-01, Vol.922 (1), p.352-354

2000

Link zum Volltext

Verfügbarkeit prüfen

Cytotoxic Activity of the Recombinant Anti-mesothelin Immunotoxin, SS1(dsFv)PE38, Towards Tumor Cell Lines Established from Ascites of Patients with Peritoneal Mesotheliomas

Anticancer research, 2004-05, Vol.24 (3A), p.1327-1335

2004

Link zum Volltext

Verfügbarkeit prüfen

Octreotide induced remission of a refractory small cell carcinoma of the endometrium

International journal of gynecological cancer, 1999-01, Vol.9 (1), p.80-85

1999

Link zum Volltext

Verfügbarkeit prüfen

Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro

Cancer research (Chicago, Ill.), 1997-10, Vol.57 (19), p.4309-4315

1997

Link zum Volltext

Verfügbarkeit prüfen

Alternative Administration of Camptothecin Analogues

Annals of the New York Academy of Sciences, 2000-01, Vol.922 (1), p.237-246

2000

Link zum Volltext

Verfügbarkeit prüfen

Effects of interleukin-1α on ovarian carcinoma in patients with recurrent disease

European journal of cancer (1990), 1996-08, Vol.32 (9), p.1609-1611

1996

Link zum Volltext

Verfügbarkeit prüfen

Quantification of the Breakpoint Cluster Region Rearrangement for Clinical Monitoring in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Blood, 1995-05, Vol.85 (10), p.2705-2710

1995

Link zum Volltext

Verfügbarkeit prüfen

Optimal modeling for phase I design of a two drug combination—results of a phase I study of cisplatin with 9-nitrocamptothecin

Investigational new drugs, 2008-12, Vol.26 (6), p.541-551

2008

Link zum Volltext

Verfügbarkeit prüfen

Activity of ALRT 1550, a new retinoid, with interferon‐γ on ovarian cancer cell lines

International journal of gynecological cancer, 2002-03, Vol.12 (2), p.202-207

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(121)

Publikationsform

Sprache

Englisch
(152)
Japanisch
(10)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(97)
Life Sciences & Biomedicine
(93)
Science & Technology
(93)
Female
(82)
Oncology
(71)
Biological And Medical Sciences
(48)
Medical Sciences
(48)
Adult
(43)
Middle Aged
(43)
Aged
(32)
Pharmacology. Drug Treatments
(22)
Antineoplastic Agents
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Male
(20)
Ovarian Neoplasms - Drug Therapy
(19)
Chemotherapy
(17)
Antineoplastic Agents, Phytogenic - Therapeutic Use
(16)
Camptothecin - Analogs & Derivatives
(16)
Obstetrics & Gynecology
(16)
Tumors
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen

Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer

Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470

Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix

Docetaxel for Patients With Paclitaxel-Resistant Müllerian Carcinoma

A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix

Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines

Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors

Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience

Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles

Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later

Absence of epidermal growth factor receptor mutations in cervical cancer

Paraneoplastic syndromes of gynecologic neoplasms

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour‐infiltrating lymphocyte (TIL)‐derived T cell lines and established tumour cell lines

Feasibility, Phase I, and Pharmacological Study of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Malignancies in the Lungs

Cytotoxic Activity of the Recombinant Anti-mesothelin Immunotoxin, SS1(dsFv)PE38, Towards Tumor Cell Lines Established from Ascites of Patients with Peritoneal Mesotheliomas

Octreotide induced remission of a refractory small cell carcinoma of the endometrium

Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro

Alternative Administration of Camptothecin Analogues

Effects of interleukin-1α on ovarian carcinoma in patients with recurrent disease

Quantification of the Breakpoint Cluster Region Rearrangement for Clinical Monitoring in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Optimal modeling for phase I design of a two drug combination—results of a phase I study of cisplatin with 9-nitrocamptothecin

Activity of ALRT 1550, a new retinoid, with interferon‐γ on ovarian cancer cell lines

Suchergebnisse filtern